EUVIMEDEUVIMED entdecken
Crossref

Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms

Prasanna Kumar Lankalapalli, Naveen Maddukuri, Ashok Morsu iD, Vijaykumar Chollety, Pranitha Sambu iD, Teja Kamireddy iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Prasanna Kumar Lankalapalli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Visual Technologies LLC, Plano, Texas, USA. Hauptthemen laut MEDLINE: Drug Contamination, Ketorolac Tromethamine, Chromatography, Reverse-Phase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present manuscript discusses the development and validation of a gradient reversed‐phase HPLC method for determining impurities in Ketorolac Tromethamine tablet dosage formulations. The analytes were separated using an Agilent Zorbax SB C8 column (250 × 4.6 mm, 5.0‐μm particle size). The mobile phase consisted of 0.05‐M ammonium phosphate buffer at pH 3.0 (mobile phase A) and a mixture of 40% methanol and 60% tetrahydrofuran (mobile phase B). The column temperature was maintained at 40°C, with a flow rate of 1.0 mL/min. UV detection was performed at 254 nm. The method demonstrated high specificity, with a linearity range of 0.201–6.445 μg/mL and achieving a correlation coefficient of > 0.999. The method exhibited high accuracy, exceeding 97%. The developed method was validated according to international ICH guidelines for specificity, linearity, precision, accuracy, and robustness. Stress studies indicated that Ketorolac Tromethamine tablets were sensitive to basic, photolytic, and oxidative stress conditions. The method was deemed suitable for quality control purposes, including impurity determination in Ketorolac Tromethamine tablets and stability‐indicating studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug ContaminationKetorolac TromethamineChromatography, Reverse-PhaseTabletsChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsLimit of DetectionDrug StabilitySensitivity and Specificity

Stichwörter der Autor:innen

HPLCKetorolac Tromethamine (KTR)PDAmethod developmentvalidation

Substanzen

TabletsKetorolac Tromethamine

Autor:innen und Institutionen

  • Visual Technologies LLC, Plano, Texas, USA.
  • Invagen Pharmaceutical Inc, Central Islip, New York, USA.
  • Thermo Fisher, Morrisville, North Carolina, USA.
  • Ascent Pharmaceuticals Inc, Central Islip, New York, USA.
  • Aurex Laboratories Pvt Ltd, Hyderabad, India.
  • August Bioservices, Nashville, Tennessee, USA.

ORCID-Profile: Ashok Morsu, Pranitha Sambu, Teja Kamireddy

Zitieren

APA

Lankalapalli, P. K., Maddukuri, N., Morsu, A., Chollety, V., Sambu, P., & Kamireddy, T. (2025). Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms. Biomedical Chromatography. https://doi.org/10.1002/bmc.70109

Vancouver

Lankalapalli PK, Maddukuri N, Morsu A, Chollety V, Sambu P, Kamireddy T. Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms. Biomedical Chromatography. 2025. doi:10.1002/bmc.70109

BibTeX
@article{Lankalapalli2025,
  author = {Lankalapalli, Prasanna Kumar and Maddukuri, Naveen and Morsu, Ashok and Chollety, Vijaykumar and Sambu, Pranitha and Kamireddy, Teja},
  title = {Stability‐Indicating RP‐HPLC Method Development and Validation for the Quantification of Ketorolac Tromethamine‐Related Impurities in Tablets Solid Oral Dosage Forms},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70109}
}
Kostenlos starten →